AMRUTANJAN vs THEMISMED: Stock Comparison

Amrutanjan Health Care Limited vs Themis Medicare Limited

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Amrutanjan Health Care Limited is the larger company by market capitalisation. Amrutanjan Health Care Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Amrutanjan Health Care Limited and Themis Medicare Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AMRUTANJAN is more favourable on 10 of 11 scored metrics and THEMISMED on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
AMRUTANJAN is the larger company
₹1,528 Cr vs ₹1,004 Cr
P/E Ratio
AMRUTANJAN has a lower P/E
26.9x vs 938.33x
P/B Ratio
THEMISMED has a lower P/B
2.6x vs 4.21x
EPS
AMRUTANJAN has higher earnings per share
₹20.01 vs ₹0.12
Dividend Yield
AMRUTANJAN has a higher dividend yield
1.02% vs 0.43%
Revenue Growth (TTM YoY)
AMRUTANJAN has faster revenue growth
10.5% vs 6.7%
EPS Growth (TTM YoY)
AMRUTANJAN has faster EPS growth
6.7% vs 0%
ROE
AMRUTANJAN has a higher ROE
20% vs 0.29%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMRUTANJANTHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricAMRUTANJANTHEMISMED
Live Price₹530₹109
Day Change-1.6%-2.98%
Volume21,75471,528
52-Week High₹790.95₹148
52-Week Low₹486₹64.95
Distance from 52W High-32.99%-26.35%

Valuation

MetricAMRUTANJANTHEMISMED
Market Cap₹1,528 Cr₹1,004 Cr
P/E Ratio26.9x938.33x
P/B Ratio4.21x2.6x
EPS₹20.01₹0.12
Book Value₹128.04₹43.06
Dividend Yield1.02%0.43%

Growth

MetricAMRUTANJANTHEMISMED
Revenue Growth (TTM YoY)10.5%6.7%
EPS Growth (TTM YoY)6.7%0%
Qtr Sales Growth6.74%
Qtr Profit Growth192%

Profitability & Leverage

MetricAMRUTANJANTHEMISMED
ROE20%0.29%
ROCE31.4%2.74%
Net Margin11.52%0.33%
Operating Margin17.7%-2.9%
Debt to Equity0.02x25.11x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMRUTANJANTHEMISMED
Promoter Holding46.52%57.5%
FII Holding2.44% 0.27 pp0.11% 0.06 pp
DII Holding12.28% 0.38 pp0.01%
Public Holding38.72% 0.11 pp32.78% 0.05 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Amrutanjan Health Care Limited and Themis Medicare Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.